ERBB2 and neoplasm: Changes in the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), oncoproteins, epithelial markers and immune system specific proteins highlight the presence of different molecular subtypes within a single tumor [1, 5, 6].